Neurological Surgery Doctors in Shenandoah, TX Accepting Medicare

8 Neurological Surgery doctors found. Showing 1 - 8

Dr. Norman Jose Torres, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1011 Medical Plaza Dr Ste 130, Shenandoah, TX 77380 Phone: 832-585-9191    Fax: 832-369-4935

Mirza N Baig, M.D., PH.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Vision Park Blvd, Suite 220, Shenandoah, TX 77384 Phone: 855-457-7463    Fax: 855-356-3876

Dr. Geoffrey Zubay, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9200 Pinecroft Dr, Ste. 130, Shenandoah, TX 77380 Phone: 713-897-5900    Fax: 713-897-2545

Dr. Sabih Tariq Effendi, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9180 Pinecroft Dr Ste 500, Shenandoah, TX 77380 Phone: 713-897-5900    Fax: 713-897-2545

Dr. Saman P Javedan, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9180 Pinecroft Dr Ste 500, Shenandoah, TX 77380 Phone: 713-897-5900    Fax: 713-897-2545

Dr. Cyril T Sebastian, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Vision Park Blvd Ste 260, Shenandoah, TX 77384 Phone: 281-719-9681    Fax: 281-791-0059

Sebastian Ramon Herrera, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9200 Pinecroft Dr, 130, Shenandoah, TX 77380 Phone: 713-897-5900    Fax: 713-897-2545

Prof. George Al Shamy, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9180 Pinecroft Dr Ste 500, Shenandoah, TX 77380 Phone: 713-897-5900

News Archive

Schering-Plough starts patient enrollment in phase 3 trial for Acadesine

Schering-Plough Corporation today announced the start of patient enrollment in RED-CABG, the Phase 3 Trial for acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA). Acadesine was licensed from PeriCor Therapeutics, Inc., a privately held specialty biopharmaceutical company.

Columbia University, Chinese Center for Disease Control to open joint pathogen discovery lab in Beijing

The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.

4D ecography for the diagnosis of prenatal cardiopathy

One of the most recent novelties in ecographic studies has been the application of a fourth dimension, i.e. movement added to three-dimensional reconstruction. According to Dr. Alcázar, "the development of the STIC system, carrying out the spatio-temporal correlation of images, adds movement to 3D ecography.

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.

Scientists discover new molecular drivers of Parkinson's disease

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis.

Read more Medical News

› Verified 3 days ago